Alkermes
ALKS
#3093
Rank
$4.87 B
Marketcap
$29.52
Share price
0.75%
Change (1 day)
-6.17%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.59 Billion USD

According to Alkermes's latest financial reports the company's total liabilities are $0.59 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.59 B-36.74%
2023-12-31$0.93 B1.45%
2022-12-31$0.92 B0.91%
2021-12-31$0.91 B3.3%
2020-12-31$0.88 B22.61%
2019-12-31$0.71 B10.13%
2018-12-31$0.65 B9.98%
2017-12-31$0.59 B14.99%
2016-12-31$0.51 B-4.53%
2015-12-31$0.54 B3.69%
2014-12-31$0.52 B
2013-03-31$0.51 B-10.91%
2012-03-31$0.58 B862.05%
2011-03-31$60.43 M-41.32%
2010-03-31$0.10 B-21.74%
2009-03-31$0.13 B-62.51%
2008-03-31$0.35 B-3.88%
2007-03-31$0.36 B-17.75%
2006-03-31$0.44 B32.62%
2005-03-31$0.33 B72.47%
2004-03-31$0.19 B-25.56%
2003-03-31$0.26 B4.01%
2002-03-31$0.25 B3.21%
2001-03-31$0.24 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Acorda Therapeutics
ACOR
$0.26 B-55.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$78.28 B 13,033.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$113.53 B 18,947.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$115.63 B 19,299.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$68.48 B 11,389.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$32.60 B 5,369.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
$66.02 B 10,976.89%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
$62.53 B 10,391.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland